Skip to main content
ByMarch 5, 2026~19 min read

TASE in 2025: Operating Leverage Worked, but the Index Move Will Decide the Quality of the Story

TASE ended 2025 with 29% revenue growth and 79% net profit growth, driven by strong trading activity, a jump in clearing-house services, and higher data revenue. But 2026 opens with a different question: whether the index move and the broader strategic agenda will improve business quality or swap a recurring engine for one-off cash.

CompanyTase

Company Overview

The Tel-Aviv Stock Exchange can look like a simple macro stock: when trading is hot, earnings jump, and when the market cools, the story resets. That reading is incomplete. In practice this is a market infrastructure business with several monetization layers sitting on the same relatively fixed cost base: trading and clearing commissions, listing fees and levies, clearing-house and custody services, market data, connectivity, and index-usage licenses. In 2025 almost all of those engines worked at the same time, which is why operating leverage was unusually strong.

What is working now is obvious. Revenue rose to NIS 563.5 million, up 29%. Costs rose only 7% to NIS 334.5 million. Profit before financing jumped 84% to NIS 229.0 million, and net profit rose 79% to NIS 181.0 million. This was not just a good year. It was a year in which a market utility with a heavy fixed-cost base got exactly the activity environment it wants.

But this is also where the real filter starts. A reader focused only on the earnings jump may read 2025 as a simple market-boom year. A reader focused only on the fact that 63% of revenue is already classified as non-transactional may reach the opposite conclusion and assume TASE has largely escaped market cyclicality. Both reads are too flat. Business quality did improve, but an important part of the step-up still leaned on a strong market, higher custody asset values, and better economics in some fee lines.

The active bottleneck has also changed. The issue is no longer demand, regulation, or practical tradability of the stock. Free float stands at 86.2%, daily turnover in early April 2026 was about NIS 29.7 million, and short interest remains low. The real question is capital allocation quality: how much of 2025 is truly recurring, how much is cyclical, and what will still belong to shareholders if TASE ends up selling or partnering around one of its cleaner recurring assets, the index business.

Four points need to be on the table immediately:

  • The earnings jump did not come only from a hot market. Clearing-house services rose 66%, listing fees and levies rose 14%, and data and connectivity revenue rose 17%.
  • Even in a peak year, pricing pressure is visible. The effective commission rate in equities fell from 0.01095% to 0.01000%, so part of the growth came despite lower yield per unit of activity.
  • The clearing-house jump was not all volume. Custody-fee revenue rose 64%, supported not only by a 24% increase in custody asset values but also by a 32% increase in the average custody fee.
  • Surplus cash did not disappear, but it has already been deployed. The company spent about NIS 202.6 million on buybacks, paid NIS 50.7 million in dividends, and actively reworked the debt structure.

Quick economic map for 2025:

Engine2025 RevenueShare of RevenueWhat really drives the economics
Trading and clearing commissionsNIS 207.1 million37%Trading volumes, fund creation and redemption flow, and effective commission rates
Listing fees and leviesNIS 100.3 million18%A semi-recurring stream tied to listed companies and funds, new listings, and indexation
Clearing-house servicesNIS 147.6 million26%Custody, member services, off-exchange clearing activity, and custody asset values
Data and connectivityNIS 105.9 million19%Market data, retail and business clients, connectivity, and index-usage licenses
Revenue mix: 2025 was broader, not just stronger

The important point is that TASE is not just a stock on trading volumes, but it is also not yet a pure software-like recurring engine detached from market regimes. In 2025 both worlds worked together. In 2026 the market will test whether they can keep working together even as management decides what to do with one of the business’s cleaner recurring assets.

Events and Triggers

The story of TASE in 2025 and early 2026 contains three material threads: an aggressive capital-allocation move via buybacks, a strategic process around the index activity, and a crowded 2026 execution calendar. Each one matters on its own. Together they change how the results should be read.

The Index Move

This is the main 2026 trigger. In June 2025 the board approved management’s review of strategic alternatives for the index activity, including a partial or full sale or a partnership with a leading international entity, and hired Jefferies to support the process. On January 21, 2026 TASE disclosed that it was already in negotiations for a sale of the index activity and a strategic collaboration with a significant international entity.

Why does that matter so much? Because the index business is no longer a side item inside the data line. In 2025 revenue from authorizations to use TASE indices reached NIS 31.8 million, up 27%, and the value of assets tracking TASE indices reached NIS 147.3 billion. That means this is not just branding or a marketing add-on. It is a recurring revenue line with clear linkage to managed assets in the market.

The upside case is easy to see: a sale or partnership could monetize an intellectual-property asset, expand international distribution, and unlock capital for other moves. The harder side is just as clear: this is exactly the kind of revenue that makes TASE less dependent on any single trading day. If the move is executed on the wrong terms, the company could end up selling a clean recurring engine too early in exchange for one-off cash.

Buyback and Financing

On January 9, 2025 TASE agreed with Manikay on a buyback of 4,622,028 shares, equal to 4.82% of issued capital excluding treasury shares, at NIS 43.79 per share and total consideration of about NIS 202.4 million. At the same time it took a new NIS 130 million loan, which was used to repay an earlier facility, and also received a NIS 120 million credit line.

This was not a technical action. It marked a shift from a surplus-cash balance sheet to a much more active capital-allocation stance. That can be read as board confidence in the economic value of the shares. It can also be read as a reminder that management is willing to use leverage even when the business itself does not need it for day-to-day operations.

The deal also carried a legal overhang for part of the year. A shareholder claimed oppression because the company bought shares at a 2% premium to market from Manikay rather than launching an offer to all shareholders. In January 2026 the court approved a non-compensated withdrawal of the action and dismissed it. The legal cloud is gone, but the question of capital-allocation quality remains even without litigation.

The 2026 Delivery Calendar

TASE enters 2026 with an unusually wide execution stack. Starting in 2026, trading moves to a Monday-Friday week. During the year the company plans to complete the beta phase of its AI-based public-company filing translation project and move to full operation. In the second half of 2026 it plans to launch PTRM, expand customer hosting capacity with a fourth co-location area, and introduce FX clearing solutions for dollar- and euro-denominated mutual funds.

Those are initiatives that can improve international profile, connectivity quality, and service depth. They also require execution. That matters because the company explicitly says that the broader idea of reorganizing the group under a new public holding company is not currently being advanced, and the focus has shifted to completing other strategic goals. In other words, 2026 is no longer a year of abstract vision. It is a year of delivery.

Efficiency, Profitability, and Competition

The core story of 2025 is classic operating leverage, but with two important caveats: part of the improvement came from a better revenue mix, and another part came despite pricing pressure. So profitability needs to be read through the usual three levers: volume, price, and mix.

Operating Leverage Worked

The company itself describes the exchange as a market infrastructure with high fixed cost and relatively low marginal cost. That is exactly what the numbers show. Revenue rose 29%, costs rose only 7%, and the earnings explosion came because the machine was already built. Even on labor, it is hard to talk about a major change in cost structure: headcount barely moved, to 276 employees at the end of 2025 from 275 a year earlier, and compensation expense rose only 3% to NIS 169.9 million.

The more attractive part is that the revenue jump did not force a step-function infrastructure upgrade. Immediate operating capacity stands at up to 100 million orders per day in each market, while the 2025 average in the main trading system was about 12 million orders per day, and the busiest day ever reached about 26.2 million. So 2025 was very strong, but still far from a true capacity bottleneck.

Revenue jumped, costs moved much less

Even in a Peak Year, Pricing Pressure Shows Up

This is where the casual reader can miss the point. Equities were the biggest engine in 2025: average daily equity turnover rose from NIS 2.198 billion to NIS 3.442 billion, up 57%, and equity revenue rose from NIS 59.0 million to NIS 84.7 million, up 44%. But the effective commission rate in equities fell from 0.01095% to 0.01000%.

So TASE benefited heavily from activity, but it did so on a lower yield base. This is not just an accounting detail. It is an important sign about real pricing power. When markets are strong, lower yield per unit of activity can still be buried inside the volume uplift. In a weaker year it would become much more visible.

Equities did most of the lifting, but the effective commission rate fell

The pressure does not stop there. In October 2025 the securities regulator approved the permanent removal of the maximum fee on off-exchange OTC transactions. That does not mean trading revenue suddenly collapses, but it does remind investors that TASE’s monopoly is over domestic market infrastructure, not over unlimited pricing freedom.

Quality Improved, but Not in the Same Way Everywhere

The good news is that the less cyclical parts of the business also improved. Clearing-house services jumped 66% to NIS 147.6 million. Within that, services to members rose 114% to NIS 65.8 million, and custody fees rose 64% to NIS 57.9 million. That means the clearing-house is no longer just an operational pipe behind trading. It is becoming a much more material growth engine in its own right.

But precision matters here too. Custody-fee revenue did not rise only because custody asset values increased from NIS 3.238 trillion to NIS 4.026 trillion. It also rose because the average custody fee increased from 0.00109% to 0.00144%. So part of the improvement came from stronger charging economics, not just higher activity.

The clearing-house jump came from both activity and stronger custody economics

The data line also looks better. Data and connectivity revenue rose 17% to NIS 105.9 million. Revenue from authorizations to use indices rose 27% to NIS 31.8 million, and revenue from retail clients rose 38% to NIS 15.0 million. That matters because these are the lines that look more like information infrastructure and less like pure market beta.

Competition, meanwhile, is more nuanced than the monopoly label suggests. At the core, TASE remains Israel’s only domestic multilateral exchange platform. But around the edges it competes constantly with private funding, OTC channels, foreign exchanges, alternative capital-raising routes, and regulation that can reshape pricing economics. Its advantage is a monopoly over infrastructure, not necessarily over price.

Cash Flow, Debt, and Capital Structure

To read 2025 correctly, two cash lenses must be separated. On the business’s cash-generation power, the year looks excellent: cash flow from operations reached NIS 289.8 million, comfortably above net profit. But if the question is real financing flexibility after all actual uses of cash, the right framing is all-in cash flexibility. The company does not disclose maintenance capex, so there is no point inventing a normalized bridge that is not in the filings.

The All-In Cash Picture

On an all-in basis, 2025 was a year of deployment, not accumulation. Opening cash was NIS 438.3 million. Operating cash added NIS 289.8 million. Investment activity consumed NIS 83.3 million, and financing activity consumed NIS 272.1 million. Closing cash fell to NIS 371.0 million.

All-in cash in 2025: the business generated cash, capital allocation used it

That is exactly why cash-generation power should not be confused with capital-allocation freedom. The business’s cash-generation power improved materially. Capital-allocation freedom narrowed somewhat because management chose to use it.

It also matters that the balance sheet is not just cash. At year-end the group held NIS 371.0 million in cash and cash equivalents and NIS 123.2 million in financial assets at fair value, together NIS 494.2 million. That is still a strong cushion. It is just no longer an unused one.

Capital Cushions Are Still Comfortable

The reassuring data is that the cushions remain comfortable. Liquidity surplus above regulatory requirements rose to NIS 310 million from NIS 172 million at the end of 2024. Capital surplus above regulatory requirements remained high at NIS 550 million, even though it fell from NIS 627 million. In the bank facilities, the company ended 2025 in compliance with all covenants: equity-to-balance-sheet ratio of 65% versus a 45% minimum, debt-coverage ratio of 0.5 versus a 2.5 ceiling, and debt-service ratio of 6.6 versus a 1.25 minimum.

The NIS 120 million credit line, extended in January 2026 for another year, was also still unused by the report date. So TASE is not sitting on the edge. But that also means the debate has shifted. The question is no longer whether the company has a cushion. It is how management chooses to use it.

What Really Changed

Up to 2024 it was easier to read TASE as a market infrastructure business that generated cash faster than it needed it. 2025 changed that read. The company is still balance-sheet strong, but it is no longer just accumulating surplus cash. It is distributing, buying back stock, refinancing debt, exploring a sale of the index activity, and advancing a broad list of strategic initiatives that may require more capital.

That is not automatically a criticism. It may be exactly the right way to run this kind of business. But once capital starts moving, the bar for analysis goes up. Investors are no longer asking only whether TASE can earn well. They are asking whether it can allocate well.

Forecast and Forward View

Four points should frame 2026:

  • The strategic revenue target has already been beaten, not merely met. The board’s 2023-2027 organic revenue CAGR target was 10% to 12%, while actual CAGR from 2023 to 2025 already reached 16%.
  • 2026 is not a maintenance year. Monday-Friday trading, PTRM, broader connectivity, FX clearing, and related projects are delivery items, not just headlines.
  • Not all initiatives matter equally. A new app, fintech collaboration, or AI tools may improve experience. The index decision can change the quality of the entire business.
  • This is a proof year. The market will test whether 2025 marked the start of a better phase in the business, or just an exceptional combination of hot markets and active capital allocation.

What Has to Happen for 2026 to Count as a Proof Year

The first axis is international alignment and access. The move to Monday-Friday trading, overseas investor roadshows, and AI-based translation of public-company filings are meant to bring the Israeli market closer to foreign capital. If that works, it can support turnover, listings, and TASE’s profile. If it works only partially, it could mean more operational burden without enough business impact.

The second axis is deeper infrastructure monetization. In the second half of 2026 the company plans to launch PTRM, expand co-location with a fourth area, and introduce dollar and euro clearing solutions for mutual funds. Those steps could enlarge the less cyclical part of the revenue base, but they need to arrive without a sharp step-up in fixed costs.

The third axis is adjacency expansion. Management plans to broaden private-market offerings, improve the direct digital interface to end users, examine fintech partnerships, and advance digital-asset use cases, including crypto custody. This is real strategic material, but for now it is still optionality. None of it yet replaces the engines that carried 2025.

Dependence on trading volumes has fallen, but not disappeared

The Index Decision: Value Created Versus Value Sold

This is the move that can change the quality of the story more than any other initiative.

MoveWhat it could improveWhat it could weaken
Sale of the index activity and strategic partnershipImmediate monetization, international distribution, a meaningful partner, and capital for other prioritiesPossible damage to a recurring revenue line linked to index usage, weaker mix quality, and greater dependence on new initiatives

The filings still do not disclose deal terms, scope, or final structure. So jumping to conclusions would be sloppy. But the evidence is already sufficient to define the debate. If TASE sells too early an activity that helps support its cleaner information revenue lines, it could end up looking better in cash and somewhat worse in recurring economics. If it brings in a partner that materially expands distribution and improves the long-term economics, the move could be exactly the step-up the market wants.

That is why 2026 looks less like a harvest year and more like a choice year. The 2025 profit is already in the numbers. Now the market will test what kind of business management actually wants to build out of that profit.

Risks

The first risk is market normalization. 2025 benefited from average daily equity turnover of NIS 3.442 billion versus NIS 2.198 billion a year earlier. If turnover moves back, operating leverage will work in the other direction too. The revenue mix is better than it used to be, but it is still not fully insulated from market cycles.

The second risk is pricing and regulation. The decline in the effective equity commission rate, the permanent removal of the OTC fee cap, and the tight regulatory regime around tariffs are reminders that TASE’s monopoly is over infrastructure, not necessarily over yield. This matters even more if 2026 is softer on volumes.

The third risk is the index move itself. A process that does not close could leave the market with an unfulfilled expectation. A process that closes on the wrong price or structure could hurt precisely the cleaner part of the revenue mix.

The fourth risk is classic infrastructure risk. The company is a critical information infrastructure, exposed to cyber, clearing, liquidity, and regulatory risks. It states that it has not experienced material cyber events that ended in intrusion or damage so far, but its status alone puts it on a much higher risk line than an ordinary listed company.

The fifth risk is overly aggressive capital allocation. 2025 showed that management is willing to use the balance sheet. What still needs to be proven is whether it can do so without damaging long-term business quality. That question exists even without litigation and even with comfortable covenants.

Short Interest View

Short data does not currently point to a crowded bearish thesis. At the end of March 2026, short interest as a percentage of float stood at 0.95% and SIR at 1.48. That is higher than the levels seen in early March, but still below the sector averages of 1.29% short float and 1.833 SIR.

The practical meaning is that the market is not approaching this story from an aggressively skeptical positioning base. The real debate is running through earnings quality, pricing, and the strategic index process, not through a heavy short setup.

Short interest rose tactically, but remains relatively low

Conclusions

TASE finishes 2025 from a position of strength. The cost base stayed controlled, almost every revenue engine worked, and the capital cushions remain thick. But the analytical focus has now moved from the profit of the past year to the quality of the business in the year ahead. What can shape the market’s next read is not another reminder that 2025 was strong, but whether management can turn that excess strength into higher-quality growth rather than only into another capital-allocation event.

Current thesis: TASE became a broader and higher-quality business in 2025, but 2026 will test whether management is strengthening recurring engines or converting part of them into one-off cash through the index move.

What changed: The business no longer relies only on trading volumes, but surplus cash is no longer passive either. Both the revenue mix and capital allocation have become more active.

Counter-thesis: It is possible that the mix has already improved enough that, even if equity turnover cools, clearing, data, levies, and the international strategy can provide the missing second leg that the story lacked in the past.

What could change the market reading in the short to medium term: clarity on the index activity, visible delivery on part of the 2026 rollout, and one simple question, whether costs stay disciplined while the company broadens itself.

Why this matters: For TASE, value is not measured only by what it earned this year, but by how much of the recurring revenue base and infrastructure monopoly still remains with shareholders after the next strategic move.

Over the next 2 to 4 quarters, the thesis strengthens if data and clearing revenue continue to deepen, if the 2026 launches arrive without cost inflation, and if the index move improves business quality instead of diluting it. It weakens if turnover normalizes quickly, if pricing pressure turns out stronger than expected, or if a potential deal brings in cash while weakening the quality of what remains in the group.

MetricScoreExplanation
Overall moat strength4.4 / 5Infrastructure monopoly, high switching friction, central market brand, and multiple revenue layers
Overall risk level2.6 / 5Strong capital and liquidity cushions, but still exposed to market cycles, regulation, and 2026 execution
Value-chain resilienceHighThe company sits at the core of trading, clearing, data, and custody, with no effective capacity bottleneck for now
Strategic clarityMediumThe direction is clear, but the index decision and the large 2026 initiative stack still need proof and execution
Short-interest posture0.95% of float and 1.48 SIRStill below the sector even after a tactical increase, so it does not currently contradict the fundamentals

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction
Follow-ups
Additional reads that extend the main thesis